Earnings Call · Q4 FY2022·2023-03-01

Q4 22EPS +20.00%·Rev n/aQ3 22EPS -42.86%·Rev n/aQ2 22EPS -12.50%·Rev n/aQ1 22EPS -84.83%·Rev n/a⚠ consensus missing

Organogenesis Holdings Inc. ORGO

Gary Gillheeney — Chief Executive Officer

Dave Francisco — Chief Financial Officer

+19.3%1d on move date+18.5% vs SPY3d+4.4%5d+2.6%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ORGO calls or request research access.

More ORGO calls Browse calls Request research access